---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-22-000101"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2022-10-31T23:59:59+00:00"
generated_at: "2026-06-22T21:31:46.417967+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics Q3 revenue up 39% to $35M; cuts FY2022 revenue guidance to $124-125M

## Summary
- Revenue $35.0M (+39% YoY); organic growth ~22% excluding MD Ortho and Pega Medical contributions of $4.4M.
- Net income $18.5M ($0.87 diluted EPS) vs net loss ($2.2M) in Q3 2021, includes $23M fair value adjustment.
- FY2022 revenue guidance lowered to $124-125M (from $127-130M); organic guidance $113-114M (15-16% growth).
- Adjusted EBITDA $1.9M vs $0.5M in Q3 2021; cash and equivalents $121.6M with no debt drawn.
- Company cites RSV infections and staffing shortages as September headwinds; Pega Medical acquisition closed in July.

## SEC filing metadata
- accession: 0001425450-22-000101
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2022-10-31T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545022000101/0001425450-22-000101-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545022000101/kids-20221031.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-22-000101
- JSON: https://secwatch.observer/filing/0001425450-22-000101.json
- Plain text: https://secwatch.observer/filing/0001425450-22-000101.txt

## Key facts
- Earnings Releases
  ORTHOPEDIATRICS CORP reported third quarter ended September 30, 2022 results: revenue $35.0 million, net income $18.5 million, EPS $0.87 per diluted share.
  - Period: third quarter ended September 30, 2022
  - Revenue: $35.0 million
  - Net income: $18.5 million
  - EPS: $0.87 per diluted share
  - Result: reported results
  source text: Total revenue for the third quarter of 2022 was $35.0 million, a 39% increase compared to $25.1 million for the same period last year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545022000101/0001425450-22-000101-index.htm
- Earnings Releases
  ORTHOPEDIATRICS CORP reported full year 2022 results: revenue $124 million to $125 million. Guidance lowered.
  - Period: full year 2022
  - Revenue: $124 million to $125 million
  - Guidance: lowered
  - Result: guidance update
  source text: For full year 2022, the Company now expects its full year revenue to be in the range of $124 million to $125 million, updated from its previous guidance range of $127 million to $130 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545022000101/0001425450-22-000101-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.